CAS 38818-50-7

4-chloro-3-nitrobenzoyl chloride

Codes：DABI-012

Application context (from source-drug indications)

静脉血栓栓塞达比加群酯甲磺酸盐栓塞达比加群酯甲磺酸盐中风达比加群酯甲磺酸盐缺血性卒中达比加群酯甲磺酸盐肺栓塞达比加群酯甲磺酸盐静脉血栓形成达比加群酯甲磺酸盐

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
达比加群酯甲磺酸盐Dabigatran Etexilate Mesylate	Tier B — Position early	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

达比加群酯甲磺酸盐优化路线steps: 3total yield: 13.6 g

ethyl 3-(pyridin-2-ylamino)propanoate→ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate→4-chloro-3-nitrobenzoic acid→4-chloro-3-nitrobenzoyl chloride→ethyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

Supplier	Product	Price band	MOQ	Lead time	Qualifications
Qualified Partner — East China API Works	Dabigatran etexilate mesylate Pharmaceutical Intermediates	询价	询价	询价	—
Unibest Nantong cGMP Site	ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate Pharmaceutical Intermediates	询价	询价	询价	—
Unibest Taizhou GMP-like Site	N-(4-cyanophenyl)-Glycine Pharmaceutical Intermediates	询价	询价	询价	—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.